The device enables detection of common aberrations in cardiovascular rhythm like atrial fibrillation and even third-degree heart blocks which can remain clinically silent for years, Saurabh Goyal, Executive Director of Nureca Pvt Ltd, which owns the Dr Trust brand, said.
Dr Trust, a home health-tech space brand, on Friday said it has launched ECG Pen which will help patients monitor their cardiovascular activities from home and share it with physicians, thus facilitating timely medical intervention in urgent situations. The device enables detection of common aberrations in cardiovascular rhythm like atrial fibrillation and even third-degree heart blocks which can remain clinically silent for years, Saurabh Goyal, Executive Director of Nureca Pvt Ltd, which owns the Dr Trust brand, said in a statement here.